日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop

通往高质量IgA血管炎肾炎临床试验的途径:多学科国际合作研讨会会议记录

Oni, Louise; Smith, Rona; Ozen, Seza; Williams, Chloe; Davies, Elin; King, Charlotte; Brogan, Paul; Haas, Mark; Barratt, Jonathan; Hafkin, Jeffrey; Eleftheriou, Despina; Keat, Karuna; Smith, Emd; Ding, Wen; Cheung, Chee; Platt, Caroline; Pillebout, Evangéline; Chetwynd, Andrew; Alladin, Areefa; Vaglio, Augusto; Jones, Caroline; Pain, Clare; Sunderkötter, Cord; Peipert, John; Barnes, Emily; Trivioli, Giorgio; Hardwick, Hayley; Morgan, Henry; Bajema, Ingeborg; Wason, James; Wade, Joshua; Sanchez-Manubens, Judith; Vernon, Kelly; Willcocks, Lisa; Harper, Lorraine; Lindsay, Lowena; Beldie, Madalina Andreea; Marlais, Matko; O'Shaughnessy, Michelle; Gkargkoula, Panagoula; Hamilton, Patrick; Bakry, Reima; Bogos, Roxana; Demir, Selcan; Brix, Silke; Appenzeller, Simone; Bansal, Tarun; Anastasa, Zoi; Marks, Stephen David; Audemard-Verger, Alexandra; Renson, Thomas; Jelusic, Marija; Jayne, David; Salama, Alan

Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial

一项随机、阳性对照、开放标签试验,旨在评估夸博司他联合德拉马尼、贝达喹啉或两者联合治疗成人肺结核患者的安全性、药代动力学和早期杀菌活性。

Dawson, Rodney; Diacon, Andreas H; De Jager, Veronique; Narunsky, Kim; Moodley, V Mischka; Stinson, Kelly W; Liu, Yongge; Zheng, Bo; Hafkin, Jeffrey

Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial

评估西贝普仑利单抗在IgA肾病中的疗效——VISIONARY试验的理论依据和基线数据

Perkovic, Vlado; Barratt, Jonathan; Lafayette, Richard; Liew, Adrian; Suzuki, Yusuke; Carroll, Kevin; Cheung, Chee Kay; Tesař, Vladimír; Trimarchi, Hernán; Wong, Muh Geot; Zhang, Hong; Xia, Jing; Fajardo, Cecile; Shah, Lokesh; Hafkin, Jeffrey; Rizk, Dana V

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

保护接触新确诊的多重耐药结核病患者的家庭成员:PHEONIx 3期临床试验研究方案

Kendall, Michelle A; Hughes, Michael D; Kim, Soyeon; Aaron, Lisa A; Naini, Linda; Suryavanshi, Nishi; Shah, N Sarita; Rouzier, Vanessa; Hafkin, Jeffrey; Sise, Thucuma; Beck, Justine; Heckman, Barbara E; Haberer, Jessica E; Harrington, Mark; Scarsi, Kimberly K; Hesseling, Anneke C; Swindells, Susan; Churchyard, Gavin J; Gupta, Amita

Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens

静脉注射康泰唑胺磷酸盐,然后口服康泰唑胺给药方案的群体药代动力学原理

Jürgen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy

Quabodepistat联合delamanid和bedaquiline治疗药物敏感性肺结核患者:一项多中心、2b/c期、开放标签、随机、剂量探索性试验方案,旨在评估其安全性和有效性

Dawson, Rodney; Diacon, Andreas H; Takuva, Simbarashe; Liu, Yongge; Zheng, Bo; Karwe, Vatsala; Hafkin, Jeffrey

Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis

在结核病小鼠模型中,康替唑利德可以替代利奈唑胺,与贝达喹啉和普瑞托马尼联合使用。

Almeida, Deepak; Li, Si-Yang; Lee, Jin; Hafkin, Barry; Mdluli, Khisimuzi; Fotouhi, Nader; Nuermberger, Eric L

Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832

在健康成人中开展的 I 期单次递增剂量和食物影响研究以及在肺结核患者中开展的 I/IIa 期多次递增剂量研究,旨在评估 OPC-167832 的药代动力学、杀菌活性、耐受性和安全性。

Dawson, Rodney; Diacon, Andreas H; Narunsky, Kim; De Jager, Veronique R; Stinson, Kelly W; Zhang, Xiaoyan; Liu, Yongge; Hafkin, Jeffrey

Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis

德拉马尼在多重耐药结核病患儿中的群体药代动力学和浓度-QTc分析

Sasaki, Tomohiro; Svensson, Elin M; Wang, Xiaofeng; Wang, Yanlin; Hafkin, Jeffrey; Karlsson, Mats O; Mallikaarjun, Suresh

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial

在儿童多重耐药结核病患者中,德拉马尼添加到优化的背景治疗方案中:一项 I/II 期临床试验的结果

Garcia-Prats, Anthony J; Frias, Melchior; van der Laan, Louvina; De Leon, Anjanette; Gler, Maria Tarcela; Schaaf, H Simon; Hesseling, Anneke C; Malikaarjun, Suresh; Hafkin, Jeffrey